Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium(R) (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)

Cipla is the first company to file for the 10mg strength MUMBAI, India, March 27, 2020 -- (Healthcare Sales & Marketing Network) -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it has ... Biopharmaceuticals, Generics, FDA Cipla, Esomeprazole, Nexium, AstraZeneca
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news